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Abstract 
Species of Genus Aspergillus are ubiquitous and have been involved in human affairs since centuries mainly due to their 
industrial applications and pathogenicity. In the recent past, larvae of Galleria mellonella are emerged as effective 
infection model for both bacteria and fungi. In this present study different species of Aspergillus have been evaluated for 
their pathogenicity by injecting G. mellonella larvae with their spores. The main findings of present work are (i) a wild 
type prototrophic laboratory strain of A. nidulans (as well as its genetic derivatives) is safe to handle in the laboratory (ii) 
A. fumigatus and A. flavus are pathogenic and (iii) previously unreported A. terreus, has quite nasty consequences for 
moth larvae and most likely constitute a health risk for humans. 
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1. Introduction 
Aspergillus niger is another industrially important species and involved in the production of citric acid and 
certain commercial enzymes. A. fumigatus, A. flavus and A. terreus can act as opportunistic organisms causing 
infections in immuno-suppressed individuals [1] and [2]. A. flavus and A. parasiticus are prominent in 
producing secondary metabolites, including aflatoxins [3] and [4]. With regard to human health risk, A. 
fumigatus arguably is the most notorious species [2]. In this regard studies on the healthy and immuno-
deficient mice demonstrated that A. flavus pathogenicity is approximately 100 times higher than A. fumigatus 
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[5] while pathogenicity of A. terreus is also well established [6] and [7]. A. niger is the low potential pathogen 
and cause otomycosis, an chronic ear infection [8], cutaneous infections and pneumonia [9]. A. nidulans 
seemed to be harmless but later unusual pathogenic features were observed [10] and [2] for example brain 
abscess [11], primary cutaneous infection [12], cerebral aspergillosis and spinal cord infection. Insects have 
been used to study the microbial pathogenicity and have replaced the use of vertebrate infection models due to 
similar response to infection by innate immune system [13] and [14]. The wax moth, G. mellonella has 
emerged as a promising invertebrate host to study fungal pathogenesis [15]-[18]. The correlation between the 
level of pathogenicity and type of host has been used to compare the response of G. mellonella larvae, an 
ethically acceptable and cost effective insect model and mammalian host, mice [19]. G. mellonella larvae 
have been successfully used to investigate the pathogenesis of fungal strains including A. fumigatus, A. flavus, 
A. niger and A. nidulans [19]-[21]. The objective of this present work was to ascertain if A. nidulans, an 
experimental eukaryotic organism is indeed safe to handle.  
2. Materials and Methods 
A group of 30 healthy larvae of G. mellonella of approximately similar size was selected for each 
treatment. Aspergillus strains (Table 1) were revived from silica gel preservation by growth on Aspergillus 
complete agar medium [22] at 30 ºC. Inocula were prepared by harvesting the spores in saline Tween 80 and 
the spore number was adjusted. Each larva was injected with 105 spores directly into the haemocoel through 
the last pro-leg [23]. The spores of highly virulent strains were also injected after heating at 70 ºC for 45 min 
(heat-killed spores). The number of colony forming units (CFU) was determined by plating out the known 
dilution of spore suspension in triplicate. Inoculated larvae were incubated at 37 ºC in Petri dish. One group of 
unmanipulated larvae and the other injected with 10 μl saline Tween 80 only were also incubated as controls. 
Larvae were scored daily for their survival up to 168 h post-inoculation. Survival probabilities for larvae were 
plotted by Kaplan-Meier method [23] and statistically analysed by Logrank test [24]. 
Table 1. Aspergillus species examined for pathogenicity. 
Aspergillus species Strain number Origin Source 
A. nidulans STA171 University of St Andrews, UK Environment 
A. nidulans C51 School of Biological Sciences, University of Birmingham, UK. Environment 
A. nidulans C49 School of Biological Sciences, University of Birmingham, UK. Environment 
A. flavus N/A Department of Medical Mycology, University of Glasgow, UK. Human infection 
A. niger IMI60286 International Mycological Institute, UK. Chinese gall 
A. niger N/A Gist-brocades, Industrial company, Netherlands. Environment 
A. terreus N/A Department of Medical Mycology, University of Glasgow, UK. Human infection 
3. Results 
Each larva was injected with approximately 22,000 viable STA171 and C51 spores, and 48,000 living 
spores of C49. The results showed that 91% larvae injected with STA171 and 86 % injected with C51 
survived 168 h post-inoculation. Larval death due to A. nidulans spores showed non-significant difference (P 
= 0.246 and 0.0737 for STA171 and C51 respectively) from control group (Fig. 1). After 168 h of larvae 
incubation with spores of strain C49, 80 % larvae survived and the mortality was significant (P = 0.006). Each 
larva was infected with approximately 29,000 viable spores of A. flavus that resulted in rapid killing of larvae 
as 90 % larvae died within 24 h of post-inoculation. After 24 h of death, a white mycelial mass was observed 
penetrating from the inside to the outside of dead larval cuticle. To confirm that these larvae died from fungal 
infection, a similar number of heat-treated A. flavus spores were injected. Infection with the heat-killed spores 
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was significantly less than the living spores. However, compared to the control group, heat-killed spores 
resulted in observable larval killing (P = 0.000531) with 70 % larvae surviving the 168 h treatment (Fig. 2). 
After 96 h of inoculation with the 42,000 living spores, 70 % of the larvae survived. The number of 
surviving larvae dropped to 30 % in 120 h and to 20 % after 168 h of spore injection. Injecting larvae with the 
heat-killed spores of A. terreus resulted in prolonged survival (P = 0.072) and 86 % larvae survived after 168 
h of injection (Fig. 3). The strains A. niger (Gb) and A. niger (IMI60286) were tested for their pathogenicity. 
The inoculum size injected was approximately 11,000 viable spores for A. niger (Gb) and around 39,000 
living spores for (IMI60286). After 72 h of infection, no deaths were recorded for either strain. However by 
the end of the 168 h incubation period, the strains exhibited different results with respect to pathogenicity (Fig. 
4). A. niger (Gb) was clearly non-pathogenic (P = 0.513) with 93 % surviving larvae after 168 h of 
inoculation. Although 80 % larvae survived by the end of experiment but statistical analyses showed larval 
mortality by A. niger strain IMI60286 was significant (P = 0.00659). 
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Fig. 1. Kaplan-Meier survival probability plot of G. mellonella larvae by A. nidulans strains. 
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Fig. 2. Kaplan-Meier survival probability plot of G. mellonella larvae by A. flavus. 
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4. Discussion 
The results presented here show that all the three strains of A. nidulans have extremely low or zero larval 
morbidity. The studies on host specialisation of Aspergillus species by St. Leger et al. [20] identified A. 
nidulans as non-pathogenic for G. mellonella larvae. However they used just 3000 spores per larva and spore 
numbers were deduced from microscopic counts only and therefore many spores may not have been viable. In 
the present study, spores of A. nidulans laboratory strain (STA171) were completely avirulent even although 
the inoculum size was much larger than that used by St. Leger and a genetically wild type strain was used in 
this study. Moreover, number of viable spores for strain C49 did not bring about large fatalities. It has been 
reported in A. fumigatus [25] also Cryptococcus neoformans [26] that the killing correlates to the inoculum 
size. The number of viable spores of C49 that injected to each larva was 48,000, more than the double counted 
for the other two strains, STA171 and C51.  
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Fig. 3. Kaplan-Meier survival probability plot of G. mellonella larvae by A. terreus. 
The results of the present study recommended A. niger (Gb) as a non-pathogenic strain. However A. niger 
strain IMI60286 caused significant larval death. This difference in the pathogenicity of two strains of the 
same species may be due to differences in the capacity of mycotoxins production. Revees and colleagues [21] 
identified an environmental isolate of A. niger for the production of gliotoxin, a fungal metabolite known as 
an immuno-suppressive agent which might have caused death of the G. mellonella larvae. Another reason 
which could explain the strain difference in pathogenicity could be the number of viable spores injected. Each 
larvae infected with A. niger (Gb) received 11,000 viable spore while for the strain IMI60286 received 39,000 
viable spores, almost four times higher than the inoculum size injected than A. niger (Gb). However, strain Gb 
experiments should be repeated with different spore inocula sizes to investigate such strain differences. In 
contrast, A. flavus (MMG) and A. terreus (MMG) were found to have the ability to kill moth larvae. To my 
knowledge, three species of Aspergillus included in this survey, A. terreus, has not been studied previously for 
pathogenicity using G. mellonella. As the strain of A. terreus used for this present study was a clinical isolate, 
it is perhaps not unsurprising that it exhibited pathogenic characteristics in our present experiment. 
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Fig. 4. Kaplan-Meier survival probability plot of G. mellonella larvae by A. niger strains. 
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